<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Simon CM</submitter><funding>SMA Foundation</funding><funding>German Research Foundation</funding><funding>NICHD NIH HHS</funding><funding>Cure SMA</funding><funding>American SIDS Institute</funding><funding>NIAAA NIH HHS</funding><funding>NINDS NIH HHS</funding><funding>Raynor Cerebellum Project</funding><funding>ROCHE</funding><funding>Project ALS</funding><funding>Grant from F. Hoffmann-La Roche</funding><funding>Grant from F. Hoffmann–La Roche</funding><pagination>2797-2811</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12416786</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>148(8)</volume><pubmed_abstract>Spinal muscular atrophy (SMA) is a neurodegenerative disease characterized by a varying degree of severity that is correlated with the reduction of SMN protein levels. Motor neuron degeneration and skeletal muscle atrophy are hallmarks of SMA, but it is unknown whether other mechanisms contribute to the spectrum of clinical phenotypes. Here, through a combination of physiological and morphological studies in mouse models and SMA patients, we identify dysfunction and loss of proprioceptive sensory synapses as key signatures of SMA pathology. We demonstrate that type 3 SMA patients exhibit impaired proprioception and that their proprioceptive synapses are dysfunctional as measured by the neurophysiological test of the Hoffmann reflex. We also show moderate loss of spinal motor neurons along </pubmed_abstract><journal>Brain : a journal of neurology</journal><pubmed_title>Proprioceptive synaptic dysfunction is a key feature in mice and humans with spinal muscular atrophy.</pubmed_title><pmcid>PMC12416786</pmcid><funding_grant_id>R01-NS114218</funding_grant_id><funding_grant_id>R01 AA027079</funding_grant_id><funding_grant_id>R01-NS102451</funding_grant_id><funding_grant_id>CU18-2886</funding_grant_id><funding_grant_id>K12HD001399</funding_grant_id><funding_grant_id>K12 HD001399</funding_grant_id><funding_grant_id>K01-HD084690</funding_grant_id><funding_grant_id>K01 HD084690</funding_grant_id><funding_grant_id>SI-1969/3-1</funding_grant_id><funding_grant_id>R01 NS102451</funding_grant_id><funding_grant_id>R01 NS125362</funding_grant_id><funding_grant_id>SI-1969/2-1</funding_grant_id><funding_grant_id>R01-NS116400</funding_grant_id><funding_grant_id>R35 NS122306</funding_grant_id><funding_grant_id>R01 NS114218</funding_grant_id><funding_grant_id>R01 NS078375</funding_grant_id><funding_grant_id>R01 NS116400</funding_grant_id><pubmed_authors>Buettner JM</pubmed_authors><pubmed_authors>Pagiazitis JG</pubmed_authors><pubmed_authors>Ensel S</pubmed_authors><pubmed_authors>Mentis GZ</pubmed_authors><pubmed_authors>Delestree N</pubmed_authors><pubmed_authors>Dreilich V</pubmed_authors><pubmed_authors>Garcia JL</pubmed_authors><pubmed_authors>Donadio S</pubmed_authors><pubmed_authors>Carlini MJ</pubmed_authors><pubmed_authors>Pellizzoni L</pubmed_authors><pubmed_authors>De Vivo DC</pubmed_authors><pubmed_authors>Simon CM</pubmed_authors><pubmed_authors>Gerstner F</pubmed_authors><pubmed_authors>Kratimenos P</pubmed_authors><pubmed_authors>Sumner CJ</pubmed_authors><pubmed_authors>Chung WK</pubmed_authors><pubmed_authors>Capogrosso M</pubmed_authors><pubmed_authors>Prat-Ortega G</pubmed_authors><pubmed_authors>Montes J</pubmed_authors><pubmed_authors>Carranza E</pubmed_authors><pubmed_authors>Weimer LH</pubmed_authors><pubmed_authors>Sowoidnich L</pubmed_authors><pubmed_authors>Pirondini E</pubmed_authors></additional><is_claimable>false</is_claimable><name>Proprioceptive synaptic dysfunction is a key feature in mice and humans with spinal muscular atrophy.</name><description>Spinal muscular atrophy (SMA) is a neurodegenerative disease characterized by a varying degree of severity that is correlated with the reduction of SMN protein levels. Motor neuron degeneration and skeletal muscle atrophy are hallmarks of SMA, but it is unknown whether other mechanisms contribute to the spectrum of clinical phenotypes. Here, through a combination of physiological and morphological studies in mouse models and SMA patients, we identify dysfunction and loss of proprioceptive sensory synapses as key signatures of SMA pathology. We demonstrate that type 3 SMA patients exhibit impaired proprioception and that their proprioceptive synapses are dysfunctional as measured by the neurophysiological test of the Hoffmann reflex. We also show moderate loss of spinal motor neurons along </description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Aug</publication><modification>2026-06-03T05:58:47.474Z</modification><creation>2026-04-25T03:17:00.052Z</creation></dates><accession>S-EPMC12416786</accession><cross_references><pubmed>39982868</pubmed><doi>10.1093/brain/awaf074</doi></cross_references></HashMap>